必威体育登录手机Agilent Technologies Inc. (NYSE: A) announced today that it has been selected asInstrument Business Outlook(IBO)2022 Company of the Year.IBO必威体育登录手机highlighted Agilent's increased growth in revenues, operating profit, and net income, noting that the gains resulted from a sustained effort to position the company for future growth.
Innovations noted included theHydroInertsource, which allows for using of hydrogen instead of helium as the carrier gas in GC/MS.Also, the introductions of new versions of theAssayMAP Bravo Protein Sample Prep Workbenchand theSeahorse XF Pro Analyzer.Innovation also took the form of acquisitions bringing in new technology and expertise for future growth, including expanding artificial intelligence (AI) capabilities with theacquisition of Virtual Control, a software that works with LC/MS and GC/MS to automate the analysis of instrument data.必威体育登录手机Agilent alsoacquired Polymer Standards Service(PSS) and ECD technology companye-MSion, adding to solutions for analyzing molecular structures and continuing to build capabilities to serve the biopharma industry.
必威体育登录手机Operationally, Agilent's significant commitment to ESG goals was noted, including a commitment tonet-zero greenhouse gas emissions by 2050, partnership activities withMyGreenLab必威体育登录手机, expansion of the Agilent'sCertified Pre-owned Instrumentsbusiness, and anew agreement with How2Recylefor standardized recycling labeling.
Tanya Samazan, managing editor atIBO必威体育登录手机noted: "Agilent's achievements were about annual results as well as years of transforming the company.必威体育登录手机Agilent thrived in 2022, showing a strong sales performance, stepped up sustainability initiatives, manufacturing expansion, and new product and M&A investments to feed future growth."
"We are pleased thatIBO必威体育登录手机has once again bestowed Agilent the tribute of being their Company of the Year, having received the same accolade in 2017," said Mike McMullen, Agilent president and CEO.必威体育赛事投注"It's rewarding to be recognized for our team's ongoing commitment to developing and delivering high-quality, reliable, and innovative products and solutions to our customers globally."
IBO必威体育赛事投注is a highly respected industry newsletter that tracks trends in the laboratory products markets, monitoring hundreds of life science and analytical instrument companies on a daily basis.IBOis a publication ofSDi, a division ofBioInformatics LLC, which offers custom market research and consulting, and strategic advisory services.